2142 — HBM Holdings Share Price
0.000.00%
Last trade - 00:00- HK$6.32bn
- HK$5.50bn
- $38.10m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.45 | ||
| Price to Tang. Book | 6.87 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 21.06 | ||
| EV to EBITDA | 2,123.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.98% | ||
| Return on Equity | 2.27% | ||
| Operating Margin | 19.01% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 14.11 | 4.31 | 40.66 | 89.5 | 38.1 | 119.87 | n/a | 47.71% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -87.23 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hbm Holdings Ltd is an investment holding company mainly engaged in the business of developing therapeutics in the fields of immuno-oncology and immunology diseases. The Company's products include HBM9161, HBM4003, HBM7008 and HBM1020. Batoclimab (HBM9161) is mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD). Tanfanercept (HBM9036) is mainly used for dry eye disease (DED). The Company also researches and develops immuno-oncology portfolio, including internally developed next generation immune-oncology assets targeting immune-desert, immune-excluded and inflamed tumors. The Company owns Harbour Mice Platform, generating fully human monoclonal antibodies in the classical two heavy and two light chain H2L2 format as well as heavy chain only (HCAb) format.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 20th, 2016
- Public Since
- December 10th, 2020
- No. of Employees
- 156
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 758,194,660
- Address
- Level 54, Hopewell Centre, 183, SUZHOU
- Web
- https://www.harbourbiomed.com/
- Phone
- Auditors
- Ernst & Young
Upcoming Events for 2142
Hbm Holdings Ltd Annual Shareholders Meeting
Half Year 2025 Hbm Holdings Ltd Earnings Release
Similar to 2142
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the HBM Holdings share price?
As of Today at 21:03 UTC, shares in HBM Holdings are trading at HK$8.21. This share price information is delayed by 15 minutes.
How has the HBM Holdings share price performed this year?
Shares in HBM Holdings last closed at HK$8.21 and the price had moved by +589.92% over the past 365 days. In terms of relative price strength the HBM Holdings share price has outperformed the FTSE Developed Asia Pacific Index by +597.8% over the past year.
What are the analyst and broker recommendations for HBM Holdings?
The overall consensus recommendation for HBM Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the HBM Holdings dividend yield?
HBM Holdings does not currently pay a dividend.
Does HBM Holdings pay a dividend?
HBM Holdings does not currently pay a dividend.
When does HBM Holdings next pay dividends?
HBM Holdings does not currently pay a dividend.
How do I buy HBM Holdings shares?
To buy shares in HBM Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of HBM Holdings?
As of the previous close price of HK$8.21, shares in HBM Holdings had a market capitalisation of HK$6.32bn.
Where are HBM Holdings shares listed?
Here are the trading details for HBM Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2142
What kind of share is HBM Holdings?
Based on an overall assessment of its quality, value and momentum HBM Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a HBM Holdings share price forecast for 2025?
The analyst consensus target price for shares in HBM Holdings is HK$1.69. That is 79.44% below the last closing price of HK$8.21.
Analysts covering HBM Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$0.10 for the next financial year.
Find out moreWhat is the trend in the HBM Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HBM Holdings. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +574.38%.
As of the last closing price of HK$8.21, shares in HBM Holdings were trading +180.3% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the HBM Holdings PE Ratio?
The HBM Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$8.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of HBM Holdings?
We do not have data on HBM Holdings' directors